Carbonic acid, (1S)-1-(5-(4-(4-(((3-chloro-2-pyridinyl)(3R)-3-piperidinylamino)carbonyl)-2-fluorophenyl)-1-methyl-1H-pyrazol-5-yl)-1H-tetrazol-1-yl)ethyl ethyl ester
PF-06815345 is under investigation in clinical trial NCT02654899 (Single Dose Study of PF-06815345 in Healthy Subjects).